Showing results (181-190 of 269) with videos related to
Sort By:
Pageof 27
Science Translational Medicine|August 22, 2014
Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNAEmily P Thi, Chad E Mire, Raul Ursic-Bedoya, et al.NPJ Vaccines|February 9, 2021
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virusThomas W Geisbert, Kathryn Bobb, Viktoriya Borisevich, et al.Biorxiv : the Preprint Server for Biology|June 3, 2024
A safe insect-based Chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaquesAwadalkareem Adam, Courtney Woolsey, Hannah Lu, et al.NPJ Vaccines|December 20, 2024
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaquesAwadalkareem Adam, Courtney Woolsey, Hannah Lu, et al.Iscience|August 13, 2019
The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola VirusLuke D Jasenosky, Cristhian Cadena, Chad E Mire, et al.Science Translational Medicine|August 10, 2012
A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challengeKatharine N Bossart, Barry Rockx, Friederike Feldmann, et al.Journal of Virology|July 28, 2010
A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatmentBarry Rockx, Katharine N Bossart, Friederike Feldmann, et al.Viruses|February 28, 2023
Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in BatsAnitha D Jayaprakash, Adam J Ronk, Abhishek N Prasad, et al.Nature|April 9, 2015
Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virusChad E Mire, Demetrius Matassov, Joan B Geisbert, et al.Nature Communications|July 29, 2020
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatmentRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.Pageof 27